KEGG   DRUG: VolociximabHelp
Entry
D06319                      Drug                                   

Name
Volociximab (USAN)
Formula
C6434H9942N1706O2040S52
Exact mass
145409.2142
Mol weight
145499.3695
Efficacy
Aging-related macular degeneration therapeutic agent, Antineoplastic, Angiogenesis inhibitor, Anti-alpha5beta1 integrin antibody
Comment
Monoclonal antibody
Treatment of solid tumors and age-related macular degeneration
Target
ITGA5/ITGB1 [HSA:3678 3688] [KO:K06484 K05719]
  Pathway
hsa04510  Focal adhesion
hsa04512  ECM-receptor interaction
hsa04810  Regulation of actin cytoskeleton
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: other families
   Integrins
    ITGA5/ITGB1
     D06319  Volociximab (USAN)
BRITE hierarchy
Other DBs
CAS: 558480-40-3
PubChem: 47207976
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system